In this supplement:
Skincare for Cancer Patients in Scandinavia
Preventive measures, earlier diagnosis, and markedly improved anticancer treatments have resulted in increasingly more patients living with or surviving cancer. Frequently cancer treatment-related cutaneous adverse events (cAEs) occur, which can severely impact patients' quality of life (QoL) and interfere with anticancer treatment outcomes. Currently, cAEs related to anticancer treatment may be under-appreciated to prevent or provide early and effective treatment. The Nordic European Cutaneous Oncodermatology Management (NECOM) project explored clinical insights in cAEs and focused on skincare regimens involving hygiene, moisturization, sun protection, and camouflage products.
Read full article here.
FULL SUPPLEMENT: SKINCARE FOR CANCER PATIENTS AND SURVIVORS IN THE EUROPEAN NORDIC REGION: A REVIEW BY THE NORDIC EUROPEAN CUTANEOUS ONCODERMATOLOGY MANAGEMENT (NECOM) GROUP
December 2021 | Volume 20 | Issue 12 | Department | Copyright © December 2021
Published online December 1, 2021
Abstract
This supplement covers the Nordic European Cutaneous Oncodermatology Management (NECOM) project, which explored clinical insights and reached a consensus on evidence and opinion-based best practice recommendations for oncology skincare programs to support all stakeholders in the Nordic European healthcare setting working with oncology patients throughout the entire continuum of care achieve optimal outcomes, improving patients' QoL. J Drugs Dermatol. 2021;20:12(Suppl):s4-14. 
